Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

EMA concludes GSK, Vir’s mAb can be used to treat high-risk COVID-19 patients

Recommendations can be used to support national advice prior to marketing authorisation

- PMLiVE

AZ, Pfizer/BioNTech COVID-19 vaccines ‘highly effective’ against Indian variant

UK study finds vaccines are likely to be effective in preventing hospitalisation/death

- PMLiVE

Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab

Trial will enrol 600 adults, aged 65 and older, from the phase 3 Pfizer/BioNTech COVID-19 vaccine trial

- PMLiVE

The Lucid Group Guide

We work hard at Lucid Group. Transforming lives, it's not a walk in the park. We’re a team. In fact, we are many teams. Working together to discover, define, design,...

Lucid Group Communications Limited

Our #LucidLife

We asked our people: Why do you do what you do? - What makes you get out of bed in the morning? The responses had a common theme - it's...

Lucid Group Communications Limited

- PMLiVE

Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s

Patients from a small phase 2a study saw their ADAS-Cog11 scores improve by 4.4 points

Happiness and wellbeing: you can have both, but they’re not the same thing

"Wellbeing needs to remain central to leadersip", writes Paul Hutchings, founder of fox&cat. In this article Paul and his network explain the difference between wellbeing and happiness. And how problems...

Fox&Cat

- PMLiVE

Market shaping for better healthcare decisions

By Tim Warren

- PMLiVE

bluebird bio’s CALD gene therapy Skysona gains positive opinion from CHMP

CHMP's marketing authorisation recommendation is a step towards gaining EU approval

Dementia Action Week

The future of dementia and the important role of healthcare communication in raising awareness

At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers

Bedrock Healthcare Communications

- PMLiVE

BeiGene, Novartis’ tislelizumab report promising topline results in nasopharyngeal cancer

In 2018, 46.9% of global cases of nasopharyngeal cancer occurred in China

- PMLiVE

Paula Hensler joins Havas Just:: as scientific director

Hensler will lead the scientific strategy and content for the healthcare comms agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links